Back to top

Versigent price target raised to $41 from $34 at RBC Capital

RBC Capital raised the firm’s price target on Versigent (VGNT) to $41 from $34 and keeps a Sector Perform rating on the shares as part of a broader...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: